Welcome to the Q1 2026 edition of Global Health & Pharma magazine, providing you with all of the latest news and features across the healthcare and pharmaceutical landscape. Q1 2026 Over the past year, the healthcare and pharmaceutical world has made remarkable progress. We’ve seen major advances in many areas, and we’re proud to present news and success stories throughout this quarter’s issue. After such an innovative and inspiring 2025, it feels as though the momentum is picking up further as 2026 begins to unfold. The global healthcare and pharmaceutical industries show absolutely no signs of slowing down, in fact, it’s developing more rapidly than ever. A major reason behind this continued growth is the increasing role of artificial intelligence in how new medicines are found and created, helping individuals all around the world. AI is now aiding researchers to identify promising drug candidates far more quickly, easing some of the heavy costs that usually come with development, and improving the chances that clinical trials succeed. There’s so much to enjoy throughout our issues, and the Q1 instalment is no different. In this issue, we invite you to meet the award winning companies contributing to this global progress. Their work spans a wide range of specialties and their success is truly testament to their dedication for the advancement of humankind and our health. We hope you enjoy perusing this edition, and find it both informative and motivational. We look forward to updating you with our Q2 issue. Sofi Parry, Senior Editor Website: ghpnews.digital AI Global Media, Ltd. (AI) takes reasonable measures to ensure the quality of the information on this web site. However, AI will not assume any legal liability or responsibility for the accuracy, correctness or completeness of any information that is available through this web site. If errors are brought to our attention, we will try to correct them. The information available through the website and our partner publications is for your general information and use and is not intended to address any particular finance or investment requirements. In particular, the information does not constitute any form of advice or recommendation by us or any of our partner publications and is not intended to be relied upon by users in making or refraining from making any investment or financial decisions. Appropriate independent advice should be obtained before making any such decision. Any arrangement made between you and any third party named in the site is at your sole risk and responsibility.
RkJQdWJsaXNoZXIy NTY1MjM3